Sana Biotechnology Inc (SANA)
NASDAQ
Quarter End | 9 2022 | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
総売上 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
営業利益 | -86.19M | -81.79M | -84.05M | -116.29M | -2.18M | -90.62M | -110.72M | -49.37M |
税引前収入 | -85.12M | -80.44M | -82.12M | -114M | 984k | -88.12M | -107.48M | -50.29M |
純利益 | -85.12M | -80.44M | -82.12M | -114M | 984k | -88.12M | -107.48M | -50.29M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -86.29M | -82.06M | -84.1M | -116.37M | -2.01M | -90.67M | -110.51M | -53.49M |
EBITDA | -82.17M | -77.59M | -79.71M | -111.84M | 2.32M | -79.36M | -106.98M | -45.48M |
年末 2023年12月31日 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 0 | 0 | 0 | 0 |
営業利益 | -13.25M | -141.15M | -286.15M | -367.98M | -272.56M | -293.14M |
税引前収入 | -13.25M | -138.33M | -285.31M | -367M | -269.48M | -283.26M |
純利益 | -13.25M | -130.78M | -285.31M | -367M | -269.48M | -283.26M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -2.099 | -3.268 | -17.644 | -1.985 | -1.411 | -1.437 |
EBIT | -13.25M | -141.18M | -286.05M | -367.67M | -273.24M | -293.19M |
EBITDA | -13.25M | -139.33M | -280.23M | -356.91M | -256.94M | -268.58M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約